Checking AXSM unusual options activity helps you spot when traders are making outsized bets on Axsome Therapeutics Inc before the broader market catches on. Axsome Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor AXSM unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching AXSM unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking AXSM unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and AXSM unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia.
Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
Catalysts rarely arrive without a footprint, and AXSM unusual options activity is often where that footprint shows up first. Our scanner tracks Axsome Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at AXSM unusual options volume on the call side or chasing put sweeps, Axsome Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
